MedPath

Italian Angelman Syndrome Registry Protocol

Completed
Conditions
Angelman Syndrome
Registration Number
NCT03650569
Lead Sponsor
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
Brief Summary

The Italian Angelman Registry is a national registry for patients with Angelman Syndrome. No experimental intervention is involved in participation. The data provided are stored in the registry according the EU General Data Protection Regulation (GDPR, enforced on 25 May 2018), unless participants wish to withdraw their child/ adult's information from the registry.

Detailed Description

Parents/caregivers of a child or an adult with Angelman Syndrome living in Italy are eligible to insert data in this registry. The individuals must have a diagnosis of Angelman Syndrome confirmed by genetic testing results. The registry has been launched in February 2018 in coincidence with the International Angelman Day and the recruitment will be open until February 2021.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
82
Inclusion Criteria
  • Molecular diagnosis of Angelman syndrome
Exclusion Criteria
  • Does not meet diagnostic criteria for Angelman Syndrome Other medical or genetic disorders (except autism)

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Medical and behavioral problems3 years

Medical and behavioral problems associated with Angelman syndrome and their prevalence.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

FROM (Fondazione per la Ricerca Ospedale Maggiore di Bergamo )

🇮🇹

Bergamo, Italy

© Copyright 2025. All Rights Reserved by MedPath